Author

W. Caufield

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

B. Freeman· 2 shared Y. Wang· 2 shared A. A. Shelat· 1 shared A. Broniscer· 1 shared A. Cortes· 1 shared A. Davidoff· 1 shared A. Gajjar· 1 shared B. A. Orr· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. Freeman

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

RBM39 degrader invigorates natural killer cells to eradicate neuroblastoma despite cancer cell plasticity

S. Singh, J. Fang, H. Jin, L.-A. Van de Velde, Q. Wu, A. Cortes, C. Morton, M. Woolard, W. Quarni, J. Steele, J. Connelly, L. He, R. Thorne, G. Turner, T. Confer, , J. Yang

This study shows that targeting RBM39 with indisulam promotes natural killer cell activity and eradicates neuroblastoma regardless of cellular state plasticity.

bioRxiv · Mar 21, 2024 · PreprintCancer Biology

Efficacy of oseltamivir treatment in influenza virus infected obese mice

R. Honce, J. C. Jones, B. Livingston, L. D. Estrada, Y. Wang, W. Caufield, B. Freeman, E. A. Govorkova, S. Schultz-Cherry

This study shows oseltamivir treatment does not improve viral clearance in obese mice and may increase viral genetic diversity and drug resistance.

bioRxiv · Apr 28, 2021 · PreprintMicrobiology

Patient-Derived Orthotopic Xenografts and Cell Lines from Pediatric High-Grade Glioma Recapitulate the Heterogeneity of Histopathology, Molecular Signatures, and Drug Response

C. He, K. Xu, X. Zhu, P. S. Dunphy, B. Gudenas, W. Lin, N. Twarog, L. D. Hover, C.-H. Kwon, L. H. Kasper, J. Zhang, X. Li, J. Dalton, B. Jonchere, K. S. Mercer, , S. J. Baker

The paper establishes patient-derived orthotopic xenograft models and cell lines from pediatric high-grade glioma that replicate histopathology, molecular signatures, and drug response, providing a resource for research.

bioRxiv · Dec 6, 2020 · PreprintCancer Biology